At a glance
- Originator Pharmacia Corporation
- Class Antiretrovirals
- Mechanism of Action RNA-directed DNA polymerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
Most Recent Events
- 18 Jun 2001 No-Development-Reported for HIV-1 infections in USA (Unknown route)